PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1992 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 32 |
| 2009 | 50 |
| 2010 | 91 |
| 2011 | 82 |
| 2012 | 73 |
| 2013 | 105 |
| 2014 | 72 |
| 2015 | 75 |
| 2016 | 79 |
| 2017 | 90 |
| 2018 | 89 |
| 2019 | 91 |
| 2020 | 153 |
| 2021 | 151 |
| 2022 | 141 |
| 2023 | 66 |
| 2024 | 97 |
| 2025 | 236 |
| 2026 | 164 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Mov Disord"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
SPG4 Hereditary Spastic Paraplegia: From Etiology to Therapy.
- Piermarini E, Baas PW.
- Mov Disord. 2026 Jul 31;41(10):2592-2605. doi: 10.1002/mds.70453.
- PMCID: PMC13686115
Piermarini E, et al.Mov Disord. 2026.PMCID: PMC13686115 -
Association Between Plasma Phosphorylated Tau-217 and Cognition in Parkinson's Disease.
- Kouchache T, Chan T, Sun S, Liu L, Delva A, Gan-Or Z, Rosa-Neto P, Gagnon JF, Dagher A, Postuma RB, Sharp M.
- Mov Disord. 2026 Jul 19;41(10):2699-2705. doi: 10.1002/mds.70400.
- PMCID: PMC13686120
Kouchache T, et al.Mov Disord. 2026.PMCID: PMC13686120 -
DNA Repair Pathway Variants Are Enriched in Individuals with Biallelic AAGGG CANVAS and RFC1-Related Disease.
- Wang X, Fearnley LG, Davies KC, Snell P, Lee S, Jackson VE, Read J, Milton M, Harding IH, Delatycki MB, Szmulewicz DJ, Lockhart PJ, Bahlo M, Rafehi H.
- Mov Disord. 2026 Jul 19;41(10):2745-2754. doi: 10.1002/mds.70428.
- PMCID: PMC13686117
Wang X, et al.Mov Disord. 2026.PMCID: PMC13686117 -
Decoding Finely Tuned Gamma Oscillations in Chronic Deep Brain Stimulation for Parkinson's Disease.
- Muller M, Rouleau EAMY, van der Gaag S, Zutt R, Hoffmann CFE, van der Gaag NA, van Essen TA, Schouten AC, Contarino MF.
- Mov Disord. 2026 Jul 17;41(10):2677-2687. doi: 10.1002/mds.70419.
- PMCID: PMC13686116
Muller M, et al.Mov Disord. 2026.PMCID: PMC13686116 -
NKX2-1 Downstream Regulatory Structural Variants Explain a Substantial Proportion of Molecular Diagnoses in Patients With Benign Hereditary Chorea.
- Wijngaard R, Dougherty-de Miguel L, Demidov G, Astuti G, Lasa-Aranzasti A, Cueto-González A, Correa-Vela M, Lázaro-Hernández C, Haaxma CA, van Karnebeek CDM, Gómez-Andrés D, Iglesias-Serrano I, van de Kamp JM, Schieving J, Trujillano L, Engelen M, Muñoz-Cabello B, Maas RPPWM, Gardeitchik T, Gonzalez V, de Vreugd A, Pérez-Sanchez C, Lloveras E, Kamsteeg EJ, Pennings M, Rey-Viñets N, Sánchez J, van Beek R, Moreno-Galdó A, Vissers LELM, Neveling K, Marcé-Grau A, Oud MM, Pérez-Dueñas B.
- Mov Disord. 2026 Jul 16;41(10):2755-2766. doi: 10.1002/mds.70432.
- PMCID: PMC13686110
Wijngaard R, et al.Mov Disord. 2026.PMCID: PMC13686110 -
Key Interventions in Friedreich's Ataxia and Their Impact on Patient Outcomes: A Systematic Review.
- Sarwinska D, Buchholz M, Iskandar A, Grobe-Einsler M, Klockgether T, Faber J, Michalowsky B.
- Mov Disord. 2026 Jul 6;41(10):2564-2591. doi: 10.1002/mds.70423.
- PMCID: PMC13686107
Sarwinska D, et al.Mov Disord. 2026.PMCID: PMC13686107 -
Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study.
- Puisieux S, Pourié E, Bonnet C, Hopes L, Frismand S, Bronner M, Roth V, Wandzel M, Sloboda N, Lambert L, Oussalah A, Julien A, Rotaru I, Guéant-Rodriguez RM, Guéant JL, Bossenmeyer-Pourié C, Renaud M.
- Mov Disord. 2026 Jul 1;41(10):2712-2722. doi: 10.1002/mds.70413.
- PMCID: PMC13686121
Puisieux S, et al.Mov Disord. 2026.PMCID: PMC13686121 -
Melanopsin-Mediated Post-Illumination Pupillary Response in Idiopathic Rapid Eye Movement (REM) Sleep Behavior Disorder and Parkinson's Disease.
- Chan JWY, Huang B, Gong S, Yang Y, Tang S, Chau SW, Chan NY, Li TM, Liu Y, Chan AYY, Ma KKY, Li SX, Tsoh J, Chong KKL, Roecklein KA, Mok VCT, Wing YK.
- Mov Disord. 2026 Jun 29;41(10):2706-2711. doi: 10.1002/mds.70412.
- PMCID: PMC13686108
Chan JWY, et al.Mov Disord. 2026.PMCID: PMC13686108 -
High-Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System Atrophy.
- Arotcarena ML, Delamarre A, Lopez-Cuina M, Martin H, Balpe E, Fioramonti X, Bezard E, Meissner WG.
- Mov Disord. 2026 Jun 29;41(10):2628-2637. doi: 10.1002/mds.70424.
- PMCID: PMC13686123
Arotcarena ML, et al.Mov Disord. 2026.PMCID: PMC13686123 -
Alkaline Phosphatases: A Potential Cause of Variability in Therapeutic Response to Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion?
- Auffret M, Vérin M.
- Mov Disord. 2026 Jun 18;41(10):2787-2788. doi: 10.1002/mds.70414.
- PMCID: PMC13686124
Auffret M, et al.Mov Disord. 2026.PMCID: PMC13686124